Frank Wang, Ph.D.

Dr. Frank Wang is currently President, CEO and Founder of BioMedomics, Inc., located at Research Triangle Park, North Carolina. BioMedomics is a biotech company focusing on drug discovery & development, and medical diagnostics. At BioMedomics, Dr. Wang is directly involved in fund raising, corporation operation, marketing and sales.
From 2001 to 2006, Dr. Wang was the President and Co-founder of BioMachines, Inc. BioMachines is an enabling technology company applying proprietary advanced technologies in the biomedical and biopharmaceutical marketplace. Prior to starting Biomachines, Dr. Wang founded US Subsidiary of JUKI, a Japanese semiconductor equipment manufacturing company and served as General Manger of JUKI Corporation’s US operations at RTP, NC (1998-2001). He created operation Infrastructure and established international business communication between Japan and US. Prior to JUKI, Dr. Wang worked at a Swiss company Zevatech (1996-1998), RTP, NC, as Senior Manger to manage product development for automated semiconductor manufacture process. Before his industry experience, Dr. Wang worked as an Assistant Professor at University of North Carolina at Chapel Hill (1993-1996) where he published a book and scientific papers on Biophysics and Bioengineering research areas. Dr. Wang received awards from Witaker Foundation, American Heart Association, and Sanofi Winthrop. He also has patents in Bioengineering and semiconductor process fields. Dr. Wang had Technology MBA training and obtained his Ph.D. in Applied Physics from Osaka University, Japan and B.S in EE from Southeast University, Nanjing, China. Dr. Wang actively involved with community service. Dr. Wang was also a speaker and lecturer for Duke Fuqua Business school about global business development related to China.